HOME >> BIOLOGY >> NEWS
Novel gene therapy on the horizon, says Brenner Children's Hospital pediatrician

WINSTON-SALEM, N.C. Researchers at Brenner Children's Hospital are working on a novel gene therapy to help new moms and their babies who suffer from genetic defects, according to findings reported at the Society of Pediatric Research in Seattle today.

R. Mark Payne, M.D., a pediatric cardiologist and researcher at Brenner Children's Hospital, has discovered a new way to transmit proteins across cell membranes a finding that in the future might prevent or treat diseases like Sudden Infant Death Syndrome (SIDS) and Trifunctional Protein (TFP) deficiency in infants and their mothers.

"The treatment involves getting the right protein into the cells or mitochondria they need to function properly," Payne said. "Mitochondria produce most of the energy within cells and defects in their function are among the most common genetic defects in the United States and currently can not be prevented."

Some genetic defects occur when mitochondria lack a certain protein, which cause babies, and in some cases their mothers, to become sick and die, Payne said. Current gene therapy attempts have tried injecting the patient with a virus that corrects the defect. However, the effectiveness of this approach is very poor and the side effects aren't good patients may die from the treatments, according to Payne.

"Instead of injecting a virus into the cells, we want to take the needed protein and inject only that protein into the cells," Payne said. "This is highly efficient technology the needed proteins get absorbed and are positioned correctly within the mitochondria located in the cell, which is necessary to correct the defect."

Payne and his colleagues say this new technology could mean that mothers suffering from genetic abnormalities such as TFP may be able to receive injections until their due date preventing premature delivery and sometimes death for both the mother and infant.

TFP is one of many genetic defects that involve mitochondria
'"/>

Contact: Rae Beasley
rabeasle@wfubmc.edu
336-716-6878
Wake Forest University Baptist Medical Center
4-May-2003


Page: 1 2

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel bacterium detoxifies chlorinated pollutants
10. Novel flu vaccine shows promise in mice
11. Novel method identifies hidden genes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2018)... (PRWEB) , ... August 07, 2018 , ... CallTower ... today their new CT Cloud Voice and SIP solutions. CT Cloud solutions are ... secure, quality voice solution that is far superior to traditional PBX systems, at a ...
(Date:8/1/2018)... ... August 01, 2018 , ... Dr. Asher Kimchi, Founder ... winning recipients of the 2018 IAC Awards at the 23rd World Congress on Heart ... also named four faculty to receive the Distinguished Fellowship Awards. , Dr. Asher Kimchi, ...
(Date:8/1/2018)... , ... August 01, 2018 , ... Visikol CEO Dr. ... services and strong pharmaceutical company partnerships that Visikol will far exceed its original 2018 ... developing its suite of digital pathology tools, whole mount imaging ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... August 08, 2018 , ... ... was developed and is continually updated by a talented scientific team that includes ... service provides: , 1. Information on the medical impact of a patient’s ...
(Date:8/9/2018)... ... August 09, 2018 , ... Simpson ... construction (AEC) experts with building owners and managers for a full-day discussion on ... Construct symposium comes to Boston for the first time on Thursday, 13 September ...
(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... ... 2 additional CE/IVD marked molecular quality controls to its expanding CE/IVD product inventory. ... controls to our expanding CE/IVD QC offerings. ZeptoMetrix remains entirely committed to fully ...
(Date:7/25/2018)... ... July 25, 2018 , ... Dimitrius Anagnos, an evidence-based ... combat inflammation and autoimmune disorders. , The preclinical research assessed biomarkers for ... was reported:, Over 70% decrease in Interleukin (IL-1ß) ...
Breaking Biology Technology:
Cached News: